A characterization of the relationship of ovarian reserve markers with age

被引:136
作者
Rosen, Mitchell P. [1 ]
Johnstone, Erica [1 ]
McCulloch, Charles E. [2 ]
Schuh-Huerta, Sonya M. [3 ]
Sternfeld, Barbara [4 ]
Reijo-Pera, Renee A. [3 ]
Cedars, Marcelle I. [1 ]
机构
[1] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94115 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94115 USA
[3] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA
[4] Kaiser Permanente, Div Res, Oakland, CA USA
基金
美国国家卫生研究院;
关键词
AFC; AMH; ovarian reserve; fertility; FSH; oocyte; follicle; ANTI-MULLERIAN HORMONE; FOLLICLE-STIMULATING-HORMONE; ANTIMULLERIAN-HORMONE; MENOPAUSAL TRANSITION; LUTEINIZING-HORMONE; NATURAL MENOPAUSE; PROVEN FERTILITY; REPRODUCTIVE AGE; DIMERIC INHIBIN; NORMAL WOMEN;
D O I
10.1016/j.fertnstert.2011.10.031
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Objective: To identify markers of ovarian age that best match the pattern of oocyte loss seen in histology specimens. Design: Cross-sectional study. Setting: University. Patient(s): Caucasian women (n = 252) aged 25-45 years. Intervention(s): none. Main Outcome Measure(s): The relationship between antral follicle count (AFC), antimullerian hormone (AMH), inhibin B, FSH, and E-2 with age was estimated using the power model, which previously has been shown to most accurately describe oocyte loss in histologic specimens. The power model was fit to each marker and used to compare the rates of change at ages 30 and 40 with the histologic pattern. Among those markers following the pattern, R-2 was used to compare the degree of relationship with age. Result(s): Both AMH levels and AFC exhibited significant progressive declines with age. The average rates of loss per year for AFC and AMH were, respectively, -0.57 and -1.09 at age 30, and -1.33 and -3.06 at age 40. FSH, inhibin B, and E-2 did not exhibit progressive rates of change. The R-2 for AFC was 27.3% and for AMH was 22.7%. Conclusion(s): Only AFC and AMH follow the pattern of oocyte loss observed histologically. Although AMH may be more cost-effective, AFC is a slightly more accurate noninvasive measure for ovarian aging. (Fertil Steril (R) 2012;97:238-43. (C) 2012 by American Society for Reproductive Medicine.)
引用
收藏
页码:238 / 243
页数:6
相关论文
共 37 条
[1]
BLOCK E, 1952, ACTA ANAT, V14, P108
[2]
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count [J].
Broer, Simtone L. ;
Mol, Ben Willem J. ;
Hendriks, Dave ;
Broekmans, Frank J. M. .
FERTILITY AND STERILITY, 2009, 91 (03) :705-714
[3]
Dimeric inhibin: a direct marker of ovarian aging [J].
Danforth, DR ;
Arbogast, LK ;
Mroueh, J ;
Kim, MH ;
Kennard, EA ;
Seifer, DB ;
Friedman, CI .
FERTILITY AND STERILITY, 1998, 70 (01) :119-123
[4]
Anti-Mullerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients [J].
Elgindy, Eman A. ;
El-Haieg, Dahlia O. ;
El-Sebaey, Azza .
FERTILITY AND STERILITY, 2008, 89 (06) :1670-1676
[5]
Faddy MJ, 1996, HUM REPROD, V11, P1484
[6]
ACCELERATED DISAPPEARANCE OF OVARIAN FOLLICLES IN MIDLIFE - IMPLICATIONS FOR FORECASTING MENOPAUSE [J].
FADDY, MJ ;
GOSDEN, RG ;
GOUGEON, A ;
RICHARDSON, SJ ;
NELSON, JF .
HUMAN REPRODUCTION, 1992, 7 (10) :1342-1346
[7]
Factors associated with age at natural menopause in a multiethnic sample of midlife women [J].
Gold, EB ;
Bromberger, J ;
Crawford, S ;
Samuels, S ;
Greendale, GA ;
Harlow, SD ;
Skurnick, J .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (09) :865-874
[8]
AGE-RELATED-CHANGES OF THE POPULATION OF HUMAN OVARIAN FOLLICLES - INCREASE IN THE DISAPPEARANCE RATE OF NONGROWING AND EARLY-GROWING FOLLICLES IN AGING WOMEN [J].
GOUGEON, A ;
ECOCHARD, R ;
THALABARD, JC .
BIOLOGY OF REPRODUCTION, 1994, 50 (03) :653-663
[9]
A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause [J].
Hansen, Karl R. ;
Knowlton, Nicholas S. ;
Thyer, Angela C. ;
Charleston, Jay S. ;
Soules, Michael R. ;
Klein, Nancy A. .
HUMAN REPRODUCTION, 2008, 23 (03) :699-708
[10]
Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol [J].
Hazout, A ;
Bouchard, P ;
Seifer, DB ;
Aussage, P ;
Junca, AM ;
Cohen-Bacrie, P .
FERTILITY AND STERILITY, 2004, 82 (05) :1323-1329